Keyes, K. M., Kaur, N., Kreski, N. T., Chen, Q., Martins, S. S., Hasin, D., Olfson, M., & Mauro, P. M. (2022). Temporal trends in alcohol, cannabis, and simultaneous use among 12th‐grade U.S. adolescents from 2000 to 2020: Differences by sex, parental education, and race and ethnicity. Alcoholism: Clinical and Experimental Research, 46(9), 1677–1686. Portico. https://doi.org/10.1111/acer.14914

Scheer, J. R., Batchelder, A. W., Bochicchio, L. A., Kidd, J. D., & Hughes, T. L. (2022). Alcohol use, behavioral and mental health help‐seeking, and treatment satisfaction among sexual minority women. Alcoholism: Clinical and Experimental Research, 46(4), 641–656. Portico. https://doi.org/10.1111/acer.14789

Livne, O., Feinn, R., Knox, J., Hartwell, E. E., Gelernter, J., Hasin, D. S., & Kranzler, H. R. (2022). Alcohol withdrawal in past‐year drinkers with unhealthy alcohol use: Prevalence, characteristics, and correlates in a national epidemiologic survey. Alcoholism: Clinical and Experimental Research, 46(3), 422–433. Portico. https://doi.org/10.1111/acer.14781

Weinberger, A. H., Zhu, J., Levin, J., Moeller, S. J., McKee, S. A., & Goodwin, R. D. (2021). Changes in alcohol use by cannabis use status among adolescents and young adults in the United States: Emerging evidence for both substitution and complementarity. Alcoholism: Clinical and Experimental Research, 45(12), 2536–2545. Portico. https://doi.org/10.1111/acer.14737

Roache, J. D., Pavlicova, M., Campbell, A., Choo, T., Peavy, M., Kermack, A. S., Nunes, E. V., & Rotrosen, J. (2021). Is extended release naltrexone superior to buprenorphine‐naloxone to reduce drinking among outpatients receiving treatment for opioid use disorder? A secondary analysis of the CTN X:BOT trial. Alcoholism: Clinical and Experimental Research, 45(12), 2569–2578. Portico. https://doi.org/10.1111/acer.14729

Mannes, Z. L., Shmulewitz, D., Livne, O., Stohl, M., & Hasin, D. S. (2021). Correlates of mild, moderate, and severe Alcohol Use Disorder among adults with problem substance use: Validity implications for DSM‐5. Alcoholism: Clinical and Experimental Research, 45(10), 2118–2129. Portico. https://doi.org/10.1111/acer.14701

Mauro, P. M., Askari, M. S., & Han, B. H. (2021). Gender differences in any alcohol screening and discussions with providers among older adults in the United States, 2015 to 2019. Alcoholism: Clinical and Experimental Research, 45(9), 1812–1820. Portico. https://doi.org/10.1111/acer.14668

Warton, F. L., Molteno, C. D., Warton, C. M. R., Wintermark, P., Lindinger, N. M., Dodge, N. C., Zöllei, L., van der Kouwe, A. J. W., Carter, R. C., Jacobson, J. L., Jacobson, S. W., & Meintjes, E. M. (2021). Maternal choline supplementation mitigates alcohol exposure effects on neonatal brain volumes. Alcoholism: Clinical and Experimental Research, 45(9), 1762–1774. Portico. https://doi.org/10.1111/acer.14672

Srivastava, A. B., Sanchez‐Peña, J., Levin, F. R., Mariani, J. J., Patel, G. H., & Naqvi, N. H. (2021). Drinking reduction during cognitive behavioral therapy for alcohol use disorder is associated with a reduction in anterior insula‐bed nucleus of the stria terminalis resting‐state functional connectivity. Alcoholism: Clinical and Experimental Research, 45(8), 1596–1606. Portico. https://doi.org/10.1111/acer.14661

Mariani, J. J., Pavlicova, M., Basaraba, C., Mamczur‐Fuller, A., Brooks, D. J., Bisaga, A., Carpenter, K. M., Nunes, E. V., & Levin, F. R. (2021). Pilot randomized placebo‐controlled clinical trial of high‐dose gabapentin for alcohol use disorder. Alcoholism: Clinical and Experimental Research, 45(8), 1639–1652. Portico. https://doi.org/10.1111/acer.14648